When to stop? Real-world decision pathways for transthyretin stabilizer discontinuation in cardiac amyloidosis

Knoll, K. and Lavall, D. and Assmus, B. and Hahn, K. and Kindermann, I and Michel, L. and Mustroph, Julian and Papathanasiou, M. and Pfister, R. and Schwarting, S. K. and Aus Dem Siepen, F. and Troebs, M. and Winzer, E. B. and Yilmaz, A. and Morbach, C. (2025) When to stop? Real-world decision pathways for transthyretin stabilizer discontinuation in cardiac amyloidosis. EUROPEAN HEART JOURNAL, 46 (Suppl1): ehaf784270. ISSN 0195-668X, 1522-9645

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin II
Depositing User: Dr. Gernot Deinzer
Date Deposited: 17 Nov 2026 08:55
Last Modified: 17 Nov 2026 08:55
URI: https://pred.uni-regensburg.de/id/eprint/67791

Actions (login required)

View Item View Item